The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...

In the final days of the Biden administration, the U.S. Department of Health and Human Services’ Centers for Medicare and ...

Changes may be on the horizon regarding the cost of diabetes and weight loss drug titans like Ozempic and Wegovy. The Biden ...

Nursing home residents that receive Medicaid benefits may be affected by a change in federal poverty level standards, which are applied to eligibility ...

The federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

The Centers for Medicare & Medicaid Services Jan. 17 announced a record 24.2 million consumers selected health coverage ...

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

Ore., urged federal health regulators Friday to fix their mistake that’s unfairly cost St. Charles Health System $6 million over a nearly three-year period. In his letter to the Centers for Medicare & ...

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...

Teva Pharmaceutical Industries sues CMS over Medicare drug pricing negotiations policy, claiming agency has unchecked ...